1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Maven Brands Inc.

Maven Brands Inc.

MJ.CN
Maven Brands Inc.CA flagCanadian Securities Exchange
0.02
CAD
- -
- -
702,817.00Market Cap
Maven Brands Inc.
MJ.CN
(Canadian Securities Exchange)

Recent

price

0.02

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
FRC
- -
- -
0.01
0.06
0.16
- -
- -
- -
- -
- -
Revenue per Share
- -
-0.62
-0.24
-0.29
-0.46
-0.51
-1.43
-0.36
-0.07
-0.02
Basic EPS, GAAP
- -
-0.19
-0.1
-0.29
-0.71
-1.04
-0.4
-0.46
-0.06
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
-0.64
-0.75
0.01
1.46
0.76
-0.59
-0.28
-0.21
-0.21
Book Value per Share
- -
-0.03
-0.13
0.05
1.74
1.08
-0.19
0.02
-0.05
-0.05
Tangible Book Value per Share
- -
4
4
6
9
11
11
17
34
35
Basic Weighted Avg Shares
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
-2,740.31
-461.04
-282.25
- -
- -
- -
- -
7,555.66
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
-2
-1
-2
-4
-6
-16
-6
-2
-1
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
-2,784.14
-472.97
-283.32
- -
- -
- -
- -
6,719
Profit Margin (%)
- -
- -
-1
- -
11
2
-7
-4
-6
-6
Working Capital
- -
- -
- -
- -
- -
2
- -
- -
- -
- -
LT Debt
- -
- -
-1
- -
15
12
-2
- -
-2
-2
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
90.33
Return on Capital (%)
- -
- -
- -
- -
-61.91
-52.59
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'23
Sep'23
Dec'23
ST Debt
6
6
6
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
35
35
35
Market Capitalization
2
1
1

Working Capital

FRC

•

in mil. unless spec.
Jun'23
Sep'23
Dec'23
Total Current Assets
1
1
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
7
7
7
Payables & Accruals
1
1
1
ST Debt
6
6
6
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
546.22%
-483.5%
Free Cash Flow
- -
55.76%
-75.53%
Net Income, GAAP
- -
47.7%
-60.39%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
-0.14
- -
- -
- -
-0.36
2022
-0.03
- -
- -
- -
-0.07
2023
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
Ipca Laboratories Limited (IPCALAB.BO)
Cipher Pharmaceuticals Inc. (CPH.TO)
Aspen Pharmacare Holdings Limited (APNHF)
Procaps Group S.A. (PROC)
Vibe Growth Corporation (VIBE.CN)
Next Science Limited (NXSCF)
Business
Maven Brands Inc. (MJ.CN), founded in 2013 and headquartered in Vernon, British Columbia, Canada, operates as a licensed processor and producer in the Canadian cannabis industry, providing seed-to-shelf solutions for craft growers and micro-cultivators nationwide; through its subsidiary Maven Cannabis, the company manages a 19,500 square foot production facility at the Monashee Gateway Business Park in Lumby, British Columbia, offering cannabis production, toll-processing and packaging, regulatory support and quality assurance services, supply contracts for co-branded nationwide distribution, small-scale microbial and analytics testing, genetic cleaning, propagation, cloning, bio-banking, and land packages for new micro-cultivation sites. It serves the medical and recreational cannabis markets under Health Canada's regulations, focusing on small-scale producers transitioning to regulated channels with comprehensive support from cultivation to commercialization; operations remain centered in North America, primarily Canada. The company recently announced a subsidiary agreement to sell subdivided land to the Village of Lumby, supporting local development while maintaining its core cannabis processing focus, amid ongoing efforts to manage regulatory compliance following a cease trade order related to delayed filings.